Developing Growth Fund
Daily price w/o sales charge as of 08/19/2019
$25.07
$0.09
YTD Returns w/o sales charge as of 08/19/2019
35.95%
Overall Morningstar RatingsSmall Growth
as of 07/31/2019
Morningstar rated the Lord Abbett Developing Growth Fund class A share 5, 4 and 5 stars among 579, 517 and 396 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 7/31/2019, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Closed to new investors, with the exception of certain retirement and benefit plans and existing mutual funds advisory programs.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Fund Basicsas of 07/31/2019
- Total Net Assets
- $2.10 B
- Inception Date
- 10/10/1973
- Dividend Frequency
- Annually
- Number of Holdings
- 98
- Minimum Initial Investment
- $1,000+
Expense Ratioas of 07/31/2019
Fund Expense Ratio :
0.93%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 42.62% | 22.26% | 24.16% | 13.51% | 17.00% | 11.11% |
| Lipper Category Avg. Small-Cap Growth Funds | 25.55% | 5.75% | 15.49% | 11.25% | 14.20% | - |
| Russell 2000® Growth Index | 21.54% | -1.22% | 12.66% | 10.21% | 13.67% | - |
| w/ sales charge | 34.46% | 15.24% | 21.75% | 12.17% | 16.31% | 10.97% |
Fund Expense Ratio :
0.93%
Fund Expense Ratio :
0.93%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 38.56% | 18.19% | 26.14% | 11.20% | 17.16% | 11.06% |
| Lipper Category Avg. Small-Cap Growth Funds | 23.56% | 5.14% | 17.09% | 9.66% | 14.82% | - |
| Russell 2000® Growth Index | 20.36% | -0.49% | 14.69% | 8.63% | 14.41% | - |
| w/ sales charge | 30.62% | 11.41% | 23.68% | 9.89% | 16.47% | 10.92% |
Fund Expense Ratio :
0.93%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 07/31/2019View Portfolio
| Holding | Assets |
|---|---|
| Everbridge, Inc. | 2.9% |
| Glaukos Corp. | 2.2% |
| Chegg, Inc. | 2.2% |
| Repligen Corp. | 2.2% |
| Planet Fitness, Inc. | 2.1% |
| Tandem Diabetes Care, Inc. | 2.0% |
| Alteryx Inc | 1.9% |
| YETI Holdings Inc | 1.9% |
| Blueprint Medicines Corp. | 1.9% |
| Inspire Medical Systems Inc | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 07/31/2019View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Not Classified | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
Investment Team
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
0.93%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 42.62% | 22.26% | 24.16% | 13.51% | 17.00% | 11.11% |
| Lipper Category Avg. Small-Cap Growth Funds | 25.55% | 5.75% | 15.49% | 11.25% | 14.20% | - |
| Russell 2000® Growth Index | 21.54% | -1.22% | 12.66% | 10.21% | 13.67% | - |
| w/ sales charge | 34.46% | 15.24% | 21.75% | 12.17% | 16.31% | 10.97% |
Fund Expense Ratio :
0.93%
Fund Expense Ratio :
0.93%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 38.56% | 18.19% | 26.14% | 11.20% | 17.16% | 11.06% |
| Lipper Category Avg. Small-Cap Growth Funds | 23.56% | 5.14% | 17.09% | 9.66% | 14.82% | - |
| Russell 2000® Growth Index | 20.36% | -0.49% | 14.69% | 8.63% | 14.41% | - |
| w/ sales charge | 30.62% | 11.41% | 23.68% | 9.89% | 16.47% | 10.92% |
Fund Expense Ratio :
0.93%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2018 | 5.09% | -9.31% |
| 2017 | 29.92% | 22.17% |
| 2016 | -2.71% | 11.32% |
| 2015 | -8.90% | -1.38% |
| 2014 | 3.25% | 5.60% |
| 2013 | 57.19% | 43.30% |
| 2012 | 10.39% | 14.59% |
| 2011 | -1.66% | -2.91% |
| 2010 | 36.54% | 29.09% |
| 2009 | 47.03% | 34.47% |
| 2008 | -47.50% | - |
| 2007 | 35.83% | - |
| 2006 | 12.45% | - |
| 2005 | 11.87% | - |
| 2004 | 6.00% | - |
| 2003 | 40.06% | - |
| 2002 | -29.54% | - |
| 2001 | -6.98% | - |
| 2000 | -17.69% | - |
| 1999 | 38.16% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2019 | 27.01% | 9.09% | - | - | 35.95% |
| 2018 | 7.16% | 14.97% | 12.18% | -23.96% | 5.09% |
| 2017 | 8.36% | 4.06% | 7.07% | 7.61% | 29.92% |
| 2016 | -10.30% | 2.24% | 10.87% | -4.32% | -2.71% |
| 2015 | 7.12% | 2.61% | -15.70% | -1.68% | -8.90% |
| 2014 | 1.67% | 0.15% | -5.75% | 7.59% | 3.25% |
| 2013 | 13.50% | 10.00% | 18.78% | 6.00% | 57.19% |
| 2012 | 12.16% | -2.68% | 5.55% | -4.19% | 10.39% |
| 2011 | 10.23% | 1.49% | -20.86% | 11.06% | -1.66% |
| 2010 | 8.21% | -7.94% | 16.47% | 17.68% | 36.54% |
| 2009 | -2.17% | 24.37% | 14.25% | 5.76% | 47.03% |
| 2008 | -21.82% | 6.65% | -11.81% | -28.60% | -47.50% |
| 2007 | 4.65% | 13.60% | 9.82% | 4.04% | 35.83% |
| 2006 | 15.98% | -6.23% | -6.80% | 10.93% | 12.45% |
| 2005 | -5.91% | 5.82% | 9.60% | 2.52% | 11.87% |
| 2004 | 2.00% | 0.20% | -7.05% | 11.58% | 6.00% |
| 2003 | -3.27% | 21.33% | 9.79% | 8.70% | 40.06% |
| 2002 | 0.07% | -11.90% | -23.81% | 4.90% | -29.54% |
| 2001 | -17.44% | 16.01% | -22.68% | 25.62% | -6.98% |
| 2000 | 3.52% | -13.67% | -0.56% | -7.37% | -17.69% |
| 1999 | 1.42% | 11.69% | -3.37% | 26.23% | 38.16% |
| 1998 | 11.49% | -2.94% | -22.00% | 28.29% | 8.27% |
| 1997 | -2.88% | 17.68% | 21.77% | -6.03% | 30.78% |
| 1996 | 8.18% | 8.18% | -2.85% | 7.46% | 22.19% |
| 1995 | 6.04% | 19.02% | 15.90% | -0.42% | 45.66% |
| 1994 | 0.16% | -8.07% | 10.54% | 4.34% | 6.20% |
| 1993 | -0.67% | 1.03% | 8.15% | 3.76% | 12.62% |
| 1992 | -2.92% | -13.34% | 5.39% | 9.32% | -3.06% |
| 1991 | 29.96% | -5.07% | 9.77% | 15.46% | 56.36% |
| 1990 | 1.18% | 11.38% | -24.62% | 10.17% | -6.41% |
| 1989 | 3.04% | 1.70% | 8.07% | 0.77% | 14.12% |
| 1988 | 8.71% | 2.49% | -4.04% | -3.23% | 3.45% |
| 1987 | 23.22% | -1.54% | 5.33% | -21.15% | 0.76% |
| 1986 | 12.02% | 1.82% | -18.44% | 7.95% | 0.42% |
| 1985 | 9.91% | -2.42% | -9.28% | 18.16% | 14.96% |
| 1984 | -15.56% | -5.27% | 1.63% | -4.54% | -22.39% |
| 1983 | 19.37% | 16.69% | -4.44% | -6.33% | 24.68% |
| 1982 | -11.29% | 1.28% | 11.66% | 29.18% | 29.58% |
| 1981 | 6.38% | 7.72% | -18.09% | 14.79% | 7.74% |
| 1980 | -8.32% | 13.37% | 24.22% | 5.17% | 35.80% |
| 1979 | 11.23% | 3.38% | 10.21% | 1.23% | 28.29% |
| 1978 | 12.74% | 18.50% | 11.85% | -9.31% | 35.51% |
| 1977 | -5.21% | 6.36% | 3.99% | 7.90% | 13.12% |
| 1976 | 25.90% | -5.36% | -5.21% | 5.87% | 19.57% |
| 1975 | 36.09% | 17.79% | -12.76% | -0.65% | 38.93% |
| 1974 | 2.02% | -14.31% | -23.96% | -3.25% | -35.69% |
| 1973 | - | - | - | - | -9.00% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 07/31/2019
The chart begins on the Fund's inception date of 10/10/1973.
Based on a hypothetical Class A share investment of $10,000 on 10/10/1973 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Everbridge, Inc. | Information Technology | 2.9% |
| Glaukos Corp. | Health Care | 2.2% |
| Chegg, Inc. | Consumer Discretionary | 2.2% |
| Repligen Corp. | Health Care | 2.2% |
| Planet Fitness, Inc. | Consumer Discretionary | 2.1% |
| Tandem Diabetes Care, Inc. | Health Care | 2.0% |
| Alteryx Inc | Information Technology | 1.9% |
| YETI Holdings Inc | Consumer Discretionary | 1.9% |
| Blueprint Medicines Corp. | Health Care | 1.9% |
| Inspire Medical Systems Inc | Health Care | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Everbridge, Inc. | Information Technology | 2.6% |
| Tandem Diabetes Care, Inc. | Health Care | 2.3% |
| Glaukos Corp. | Health Care | 2.1% |
| Repligen Corp. | Health Care | 2.0% |
| Planet Fitness, Inc. | Consumer Discretionary | 2.0% |
| Insperity, Inc. | Industrials | 2.0% |
| Five9, Inc. | Information Technology | 2.0% |
| Chegg, Inc. | Consumer Discretionary | 1.9% |
| Alteryx Inc | Information Technology | 1.9% |
| Coupa Software Inc | Information Technology | 1.8% |
| Generac Holdings, Inc. | Industrials | 1.7% |
| YETI Holdings Inc | Consumer Discretionary | 1.7% |
| Blueprint Medicines Corp. | Health Care | 1.6% |
| Penumbra, Inc. | Health Care | 1.6% |
| CareDx Inc | Health Care | 1.6% |
| Bright Horizons Family Solutions, Inc. | Consumer Discretionary | 1.6% |
| Etsy, Inc. | Consumer Discretionary | 1.6% |
| Fox Factory Holding Corp. | Consumer Discretionary | 1.6% |
| uniQure NV | Health Care | 1.4% |
| Inspire Medical Systems Inc | Health Care | 1.4% |
| Trade Desk, Inc./The | Information Technology | 1.4% |
| Inphi Corp. | Information Technology | 1.4% |
| Coherus Biosciences, Inc. | Health Care | 1.4% |
| eHealth, Inc. | Financials | 1.3% |
| Argenx SE | Health Care | 1.3% |
| Guardant Health Inc | Health Care | 1.3% |
| Grand Canyon Education, Inc. | Consumer Discretionary | 1.3% |
| GW Pharmaceuticals plc | Health Care | 1.2% |
| Mimecast Ltd. | Information Technology | 1.2% |
| Globant SA | Information Technology | 1.2% |
| Wix.com Ltd. | Information Technology | 1.2% |
| Roku Inc | Consumer Discretionary | 1.2% |
| Cargurus Inc | Communication Services | 1.2% |
| Okta Inc | Information Technology | 1.2% |
| Avalara Inc | Information Technology | 1.2% |
| Twilio, Inc. | Information Technology | 1.2% |
| Masimo Corp. | Health Care | 1.2% |
| Axon Enterprise, Inc. | Industrials | 1.1% |
| Paylocity Holding Corp. | Information Technology | 1.1% |
| iRhythm Technologies, Inc. | Health Care | 1.1% |
| Mirati Therapeutics, Inc. | Health Care | 1.0% |
| Stitch Fix Inc | Consumer Discretionary | 1.0% |
| BJ's Wholesale Club Holdings Inc | Consumer Staples | 1.0% |
| Strategic Education, Inc. | Consumer Discretionary | 1.0% |
| Cactus Inc | Energy | 1.0% |
| Malibu Boats, Inc. | Consumer Discretionary | 1.0% |
| Zscaler Inc | Information Technology | 1.0% |
| Verra Mobility Corp | Information Technology | 1.0% |
| Sage Therapeutics, Inc. | Health Care | 1.0% |
| RBC Bearings, Inc. | Industrials | 1.0% |
| HubSpot, Inc. | Information Technology | 1.0% |
| iRobot Corp. | Consumer Discretionary | 0.9% |
| Chart Industries, Inc. | Industrials | 0.9% |
| Anaplan Inc | Information Technology | 0.9% |
| Appian Corp | Information Technology | 0.9% |
| Calavo Growers, Inc. | Consumer Staples | 0.8% |
| Acacia Communications, Inc. | Information Technology | 0.8% |
| RingCentral, Inc. | Information Technology | 0.8% |
| NV5 Global, Inc. | Industrials | 0.8% |
| Paycom Software, Inc. | Information Technology | 0.8% |
| Denali Therapeutics Inc | Health Care | 0.8% |
| World Wrestling Entertainment Inc | Communication Services | 0.8% |
| Semtech Corp. | Information Technology | 0.8% |
| Insulet Corp. | Health Care | 0.6% |
| RealReal Inc/The | Consumer Discretionary | 0.6% |
| Amarin Corp. plc | Health Care | 0.6% |
| Elastic NV | Information Technology | 0.6% |
| Jumia Technologies AG | Consumer Discretionary | 0.6% |
| Monolithic Power Systems, Inc. | Information Technology | 0.6% |
| Invitae Corp | Health Care | 0.6% |
| Audentes Therapeutics Inc | Health Care | 0.6% |
| New Relic, Inc. | Information Technology | 0.6% |
| Tactile Systems Technology, Inc. | Health Care | 0.6% |
| Novanta Inc | Information Technology | 0.5% |
| Trex Co., Inc. | Industrials | 0.5% |
| Nevro Corp. | Health Care | 0.5% |
| Teladoc Health | Health Care | 0.5% |
| Sarepta Therapeutics, Inc. | Health Care | 0.5% |
| Bridgebio Pharma Inc | Health Care | 0.5% |
| CenterState Banks, Inc. | Financials | 0.5% |
| SVMK Inc | Information Technology | 0.5% |
| Webster Financial Corp. | Financials | 0.5% |
| Upland Software Inc | Information Technology | 0.5% |
| Evercore Partners, Inc. | Financials | 0.4% |
| Yext Inc | Information Technology | 0.4% |
| Goosehead Insurance Inc | Financials | 0.4% |
| Alarm.com Holdings, Inc. | Information Technology | 0.4% |
| Lovesac Co/The | Consumer Discretionary | 0.4% |
| Adaptive Biotechnologies Corp | Health Care | 0.4% |
| Codexis Inc | Health Care | 0.4% |
| Allogene Therapeutics Inc | Health Care | 0.4% |
| Cubic Corp | Industrials | 0.4% |
| Agios Pharmaceuticals, Inc. | Health Care | 0.3% |
| Myovant Sciences Ltd | Health Care | 0.3% |
| Western Alliance Bancorp | Financials | 0.3% |
| Pagerduty Inc | Information Technology | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 07/31/2019
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.5%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Not Classified |
1.4%
|
|
| Consumer Discretionary |
1.3%
|
|
| Consumer Staples |
0.2%
|
|
| Energy |
0.1%
|
|
| Financials |
1.4%
|
|
| Health Care |
0.3%
|
|
| Industrials |
0.1%
|
|
| Information Technology |
0.1%
|
|
| Materials | 0.0% |
Portfolio Details as of 07/31/2019
- Total Net Assets
- $2.10 B
- Number of Holdings
- 98
- Weighted Average Market Cap.
- 4.8 B
- P/B Ratio
- 9.6x
- P/E Ratio
- 44.7x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 06/28/2019
Contributors
| Holding | Contribution |
|---|---|
| Array Biopharma, Inc. | 0.9% |
| Okta Inc | 0.7% |
| Coupa Software Inc | 0.7% |
| Repligen Corp. | 0.6% |
| Beyond Meat Inc | 0.6% |
Detractors
| Holding | Contribution |
|---|---|
| Myovant Sciences Ltd | -0.5% |
| iRobot Corp. | -0.4% |
| Chart Industries, Inc. | -0.2% |
| Acacia Communications, Inc. | -0.2% |
| World Wrestling Entr | -0.2% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Developing Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 08/19/2019
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 02/14/1997 | 02/18/1997 | 03/03/1997 | $0.00000 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/20/2019 | 11/21/2019 | 11/21/2019 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/19/2018 | 11/20/2018 | $6.2452 | - | $6.2452 | $18.98 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/20/2019 | 11/21/2019 |
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 08/19/2019
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $26.60 |
| $50,000 to $99,999 | 4.75% | 4.00% | $26.32 |
| $100,000 to $249,999 | 3.95% | 3.25% | $26.10 |
| $250,000 to $499,999 | 2.75% | 2.25% | $25.78 |
| $500,000 to $999,999 | 1.95% | 1.75% | $25.57 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $25.07 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 07/31/2019
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||